Home›Grant Finder›Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
Sponsored by National Institutes of Health
Award
Varies — see funder site
Deadline
June 22, 2026
Geography
Open nationwide
Eligible organization types
Open to most organization types — confirm on funder site.